Exosome-like nanoplatform modified with targeting ligand improves anti-cancer and anti-inflammation effects of imperialine.
Lin Q, Qu M, Zhou B, Patra HK, Sun Z, Luo Q, Yang W, Wu Y, Zhang Y, Li L, Deng L, Wang L, Gong T, He Q, Zhang L, Sun X, Zhang Z.
Lin Q, et al. Among authors: li l.
J Control Release. 2019 Oct;311-312:104-116. doi: 10.1016/j.jconrel.2019.08.037. Epub 2019 Sep 1.
J Control Release. 2019.
PMID: 31484040